Endocrinology, Diabetes & Metabolism Doctors in Burlington, MA Accepting Medicare

10 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 10

Angela M Restrepo, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Lahey Clinic, Burlington, MA 01805 Phone: 781-744-8000    Fax: 781-744-5348

Artemis G Pazianos, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000    Fax: 781-744-5215

Antoine Fouad Arkieh, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 8 Kimball Ct, Burlington, MA 01805 Phone: 781-365-0024

Eugene P Clerkin, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 41 Mall Rd, Lahey Clinic, Burlington, MA 01805 Phone: 781-744-8000    Fax: 781-744-5348

Sathyavani M Prabhakar, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Lahey Hospital And Medical Center, Burlington, MA 01805 Phone: 855-934-4488    Fax: 781-744-5636

Mary Beth Hodge, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000    Fax: 781-744-5348

Dr. Iqra Javeed, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: Lahey Hospital & Medical Center, 41 Mall Road, Burlington, MA 01805 Phone: 781-744-2088    Fax: 781-744-5348

Gary W Cushing, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-8000    Fax: 781-744-5348

Leo Tchong Jr., MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Lahey Clinic, Burlington, MA 01805 Phone: 781-744-8000    Fax: 781-744-2619

Dinamarie C Garcia Banigan, MD MPH Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 41 Mall Rd, Burlington, MA 01805 Phone: 781-744-5100

News Archive

Campaign gives Florida residents 30,000 flu shots for free

Phones at Get Healthy Florida are ringing non-stop with people in search of the influenza vaccine. Calls are from mothers who have just received word that their children's pediatrician couldn't obtain the vaccine, and seniors who have gone from clinic to clinic only to find most shots are gone.

Enterprise Therapeutics doses first subjects in Phase I trial for novel cystic fibrosis therapy ETD001

Enterprise Therapeutics Ltd today announced it has successfully dosed the first subjects in a Phase 1 trial for its novel inhaled cystic fibrosis therapy, ETD001.

News round up: UniCare will drop health coverage for Virginians; Hawaii concerned about lack of physicians

The Washington Post: "About 3,000 Virginians who have health insurance through UniCare, a private insurer, will lose that coverage Jan. 1, a UniCare spokesman said Monday. Most live in Northern Virginia and get their coverage through the individual market, officials said.

Regular consumption of pistachios lowers risk of CHD: Study

A new nut and blood lipid study published on May 10, 2010, in Archives of Internal Medicine, led by Dr. Joan Sabate and colleagues at Loma Linda University (Loma Linda, Calif.), confirms that eating nuts, like pistachios, have a total and LDL (bad)-cholesterol-lowering effect, supporting the evidence that regular nut consumption can lower the risk of coronary heart disease.

European Commission approves new indication for ORENCIA in combination with MTX for RA

Bristol-Myers Squibb Company has today announced that on 1 July 2010 the European Commission approved a new indication for ORENCIA® (abatacept), in combination with methotrexate (MTX), for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have responded inadequately to previous therapy with one or more disease-modifying anti-rheumatic drugs (DMARDs) including MTX or a TNF-alpha inhibitor.

Read more Medical News

› Verified 3 days ago